JMKX 001149
Alternative Names: JMKX-001149Latest Information Update: 18 Nov 2022
At a glance
- Originator Jemincare
- Class Heart failure therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cerebral infarction; Myocardial infarction
Most Recent Events
- 03 Aug 2022 Early research in Cerebral infarction in China (unspecified route) (Jemincare pipeline, August 2022)
- 03 Aug 2022 Early research in Myocardial infarction in China (unspecified route) (Jemincare pipeline, August 2022)